Company intelligence / Profile preview
Genvira Biosciences
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
Overview
Genvira Biosciences is an active Canadian biotechnology company specializing in viral and non-viral engineering for the development of gene therapies, cancer vaccines, and advanced cell engineering solutions. The company is currently engaged in collaborative pre-clinical research to develop novel immunotherapies for malignant melanoma, leveraging its viral vector platforms and partnering on advanced disease modeling and biomanufacturing[2][7]. There is no publicly available evidence of clinical-stage programs or marketed products.
- Therapeutic areas
- Oncology
- Modalities
- Viral vectorGene therapyDNA vaccineRNA vaccinemRNA-based drugCell engineering (viral/non-viral)
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Genvira Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genvira Biosciences.